FLUO.ST
FluoGuide A/S [FLUO.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
FLUO.ST Stock Summary
Top 10 Correlated ETFs
FLUO.ST
Top 10 Correlated Stocks
FLUO.ST
In the News
FLUO.ST Financial details
Company Rating
Neutral
Market Cap
552.57M
Income
-38.38M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
7
Optionable
No
Shortable
Yes
Earnings
29 May 2024
P/E
-15.99
Forward P/E
-
PEG
-85.95
P/S
-
P/B
35.7
P/C
-
P/FCF
-18.53
Quick Ratio
1.69
Current Ratio
3.95
Debt / Equity
0.85
LT Debt / Equity
0.05
-
-
EPS (TTM)
-2.19
EPS next Y
-
EPS next Q
-
EPS this Y
8.37%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-15.09%
SMA50
-28.57%
SMA100
-40%
Inst Own
-
Inst Trans
-
ROA
-164%
ROE
-167%
ROC
-2.49%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
43.55-99.8
52W High
-54.8%
52W Low
+4.07%
RSI
40
Rel Volume
0.73
Avg Volume
9.12K
Volume
6.7K
Perf Week
-2.51%
Perf Month
-14.6%
Perf Quarter
-48.56%
Perf Half Y
-49.72%
-
-
-
-
Beta
1.068
-
-
Volatility
0.96%, 3.36%
Prev Close
0.11%
Price
44.75
Change
0.45%
FLUO.ST Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | -1.49 | -1.78 | -2.15 | -2.33 | 0 | |
| Operating cash flow per share | -1.63 | -0.9 | -1.36 | -3.21 | 0 | |
| Free cash flow per share | -1.69 | -0.9 | -1.36 | -3.22 | 0 | |
| Cash per share | 0.36 | 1.09 | 4.24 | 2.22 | 0 | |
| Book value per share | 0.7 | 0.45 | 3.51 | 2.73 | 0 | |
| Tangible book value per share | 0.64 | 0.41 | 3.47 | 2.7 | 0 | |
| Share holders equity per share | 0.7 | 0.45 | 3.51 | 2.73 | 0 | |
| Interest debt per share | 0.15 | 0.03 | 0.02 | 0.03 | 0 | |
| Market cap | 25.34M | 638.38M | 687.25M | 292.48M | 0 | |
| Enterprise value | 22.99M | 627.96M | 640.54M | 266.68M | -10.84M | |
| P/E ratio | -2.62 | -36.56 | -28.91 | -10.7 | 0 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -2.4 | -72.16 | -45.63 | -7.77 | 0 | |
| PFCF ratio | -2.32 | -72.16 | -45.63 | -7.76 | 0 | |
| P/B Ratio | 5.58 | 144.73 | 17.76 | 9.15 | 0 | |
| PTB ratio | 5.58 | 144.73 | 17.76 | 9.15 | 0 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -2.14 | -28.52 | -22.17 | -8.23 | 0 | |
| EV to operating cash flow | -2.18 | -70.98 | -42.53 | -7.08 | 0.34 | |
| EV to free cash flow | -2.1 | -70.98 | -42.53 | -7.07 | 0.34 | |
| Earnings yield | -0.38 | -0.03 | -0.03 | -0.09 | 0 | |
| Free cash flow yield | -0.43 | -0.01 | -0.02 | -0.13 | 0 | |
| Debt to equity | 0 | 0.05 | 0 | 0.01 | 0.85 | |
| Debt to assets | 0 | 0.01 | 0 | 0.01 | 0.37 | |
| Net debt to EBITDA | 0.22 | 0.47 | 1.62 | 0.8 | 0 | |
| Current ratio | 6.97 | 1.31 | 3.62 | 9.55 | 1.74 | |
| Interest coverage | -11.13 | -434.02 | -134.51 | -186.67 | 0 | |
| Income quality | 0.9 | 0.4 | 0.51 | 1.15 | 0.72 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.07 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Capex to operating cash flow | 0.04 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | -0.25 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 4.85 | 4.25 | 13.04 | 11.96 | 0 | |
| ROIC | -1.95 | -3.59 | -0.61 | -0.84 | 0 | |
| Return on tangible assets | -1.99 | -1.07 | -0.45 | -0.78 | 0 | |
| Graham Net | 0.25 | -0.17 | 2.91 | 1.91 | 0 | |
| Working capital | 4.15M | 3.83M | 38.22M | 31.24M | 12M | |
| Tangible asset value | 4.16M | 4.03M | 38.32M | 31.59M | 12.34M | |
| Net current asset value | 4.15M | 3.77M | 38.22M | 31.24M | 11.37M | |
| Invested capital | 0 | 0.05 | 0 | 0.01 | 0.85 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 200.72K | 1.54M | 4.76M | 4.22M | 2.85M | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | -2.13 | -3.96 | -0.61 | -0.86 | 0 | |
| Capex per share | -0.06 | 0 | 0 | -0.01 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | -0.9 | -0.81 | -0.6 | -0.78 | 0 | |
| Operating cash flow per share | -0.47 | -0.82 | -0.68 | -0.75 | 0 | |
| Free cash flow per share | -0.47 | -0.82 | -0.68 | -0.75 | 0 | |
| Cash per share | 2.2 | 1.38 | 0.68 | 0.75 | 0 | |
| Book value per share | 2.71 | 1.95 | 1.37 | 1.37 | 0 | |
| Tangible book value per share | 2.67 | 1.92 | 1.34 | 1.34 | 0 | |
| Share holders equity per share | 2.71 | 1.95 | 1.37 | 1.37 | 0 | |
| Interest debt per share | 0.02 | 0.02 | 0.02 | 0.02 | 0 | |
| Market cap | 294.82M | 783.86M | 619.82M | 657.65M | 0 | |
| Enterprise value | 269.01M | 767.73M | 611.95M | 648.91M | -10.84M | |
| P/E ratio | -6.95 | -20.55 | -21.71 | -17.65 | 0 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -53.18 | -81.04 | -76.45 | -73.73 | 0 | |
| PFCF ratio | -53.18 | -81.04 | -76.45 | -73.73 | 0 | |
| P/B Ratio | 9.22 | 34.12 | 38.09 | 40.14 | 0 | |
| PTB ratio | 9.22 | 34.12 | 38.09 | 40.14 | 0 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -23.97 | -66.34 | -71.27 | -60.08 | 0.86 | |
| EV to operating cash flow | -48.52 | -79.38 | -75.48 | -72.75 | 2.12 | |
| EV to free cash flow | -48.52 | -79.38 | -75.48 | -72.75 | 2.12 | |
| Earnings yield | -0.04 | -0.01 | -0.01 | -0.01 | 0 | |
| Free cash flow yield | -0.02 | -0.01 | -0.01 | -0.01 | 0 | |
| Debt to equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.85 | |
| Debt to assets | 0.01 | 0 | 0.01 | 0.01 | 0.37 | |
| Net debt to EBITDA | 2.3 | 1.39 | 0.92 | 0.81 | 0.86 | |
| Current ratio | 9.55 | 5.42 | 7 | 3.95 | 1.74 | |
| Interest coverage | 3.77K | -204.3 | 0 | 0 | 0 | |
| Income quality | 0.49 | 0.83 | 0.92 | 0.81 | 0.41 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 7.39 | 5.96 | 4.3 | 4.91 | 0 | |
| ROIC | -0.33 | -0.41 | -0.42 | -0.55 | -0.52 | |
| Return on tangible assets | -0.3 | -0.34 | -0.37 | -0.42 | -0.42 | |
| Graham Net | 1.89 | 0.95 | 0.4 | 0.25 | 0 | |
| Working capital | 31.24M | 22.31M | 15.53M | 15.65M | 12M | |
| Tangible asset value | 31.59M | 22.59M | 15.89M | 16.01M | 12.34M | |
| Net current asset value | 31.24M | 22.31M | 14.8M | 14.98M | 11.37M | |
| Invested capital | 0.01 | 0.01 | 0.01 | 0.01 | 0.85 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 2.68M | 3.2M | 3.57M | 3.73M | 4.61M | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | -0.33 | -0.42 | -0.44 | -0.57 | -0.97 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
FLUO.ST Frequently Asked Questions
What is FluoGuide A/S stock symbol ?
FluoGuide A/S is a DK stock and trading under the symbol FLUO.ST
What is FluoGuide A/S stock quote today ?
FluoGuide A/S stock price is $44.75 today.
Is FluoGuide A/S stock public?
Yes, FluoGuide A/S is a publicly traded company.
Company Profile
- Volume Average 9.12K
- Market Capitalization 552.57M
- Employee 7
- CEO Mr. Morten Albrechtsen B.B.A., BBA, M.D.
- Headquarters Copenhagen,DK
- IPO Date 2019-06-17
-
Website
https://fluoguide.com 
FluoGuide A/S, a life science company, engages in the development and sale of surgical solutions in Denmark. Its lead product candidate is FG001, which is in Phase I/II for the treatment of high-grade glioma, as well as Phase II clinical trial for the treatment of lung cancer. The company also develops FG002, which is in preclinical stage that allows surgeons to differentiate cancer from normal tissue during surgery through a novel uPAR-targeted luminescent technology. FluoGuide A/S has an agreement with Linköping University Hospital for the development of FG001 that is in the Phase I/II clinical trial for surgical removal of brain cancer; and a collaboration with Copenhagen University Hospital. The company was incorporated in 2018 and is headquartered in Copenhagen, Denmark.
